Prelude Therapeutics Incorporated (PRLD) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.06
Day's range
$3.46

Prelude Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 05/15/2026 10.91 M $37.31 M   0.00% 14.18%
BAKER BROS. ADVISORS LP 05/15/2026 10.12 M $34.62 M   0.00% 13.16%
KYNAM CAPITAL MANAGEMENT, LP 05/15/2026 1.59 M $5.45 M   101.88% 2.07%
05/15/2026 1.23 M $4.21 M   100.00% 1.60%
ECOR1 CAPITAL, LLC 05/15/2026 947.05 K $3.24 M   100.00% 1.23%
TWO SIGMA INVESTMENTS, LP 05/15/2026 923.63 K $3.16 M   17.11% 1.20%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2026 558.34 K $1.91 M   354.85% 0.73%
ACADIAN ASSET MANAGEMENT LLC 05/13/2026 511.52 K $1.75 M   -4.51% 0.66%
MILLENNIUM MANAGEMENT LLC 05/15/2026 382.74 K $1.31 M   153.47% 0.50%
MARSHALL WACE, LLP 05/15/2026 358.91 K $1.23 M   31.04% 0.47%
MORGAN STANLEY 05/15/2026 322.16 K $1.10 M   -3.81% 0.42%
BLACKROCK, INC. 05/13/2026 321.89 K $1.10 M   20.88% 0.42%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 302.46 K $1.03 M   10.84% 0.39%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 275.20 K $941.18 K   1.44% 0.36%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 267.79 K $915.84 K   97.03% 0.35%
GOLDMAN SACHS GROUP INC 05/15/2026 236.47 K $808.72 K   101.29% 0.31%
JANE STREET GROUP, LLC 05/12/2026 192.96 K $659.93 K   73.78% 0.25%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 157.38 K $538.24 K   100.00% 0.20%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 152.83 K $522.66 K   100.00% 0.20%
STATE STREET CORP 05/15/2026 138.23 K $472.75 K   8.59% 0.18%
CITADEL ADVISORS LLC 05/15/2026 124.38 K $425.37 K   100.00% 0.16%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 109.09 K $373.07 K   136.68% 0.14%
UBS GROUP AG 05/05/2026 64.51 K $220.61 K   3,373.61% 0.08%
HRT FINANCIAL LP 05/14/2026 58.70 K $200.00 K   100.00% 0.08%
XTX TOPCO LTD 05/15/2026 57.19 K $195.59 K   14.02% 0.07%
BANK OF AMERICA CORP /DE/ 05/18/2026 56.53 K $193.32 K   476.32% 0.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 05/15/2026 53.50 K $182.97 K   0.00% 0.07%
NORTHERN TRUST CORP 05/14/2026 50.12 K $171.41 K   0.00% 0.07%
COLONY GROUP, LLC 05/15/2026 50.01 K $171.02 K   0.00% 0.07%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 35.21 K $119.69 K   100.00% 0.05%
CERITY PARTNERS LLC 05/15/2026 32.88 K $112.43 K   -0.24% 0.04%
OMERS ADMINISTRATION CORP 05/15/2026 32.70 K $111.83 K   -55.21% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 21.00 K $71.82 K   100.00% 0.03%
PRUDENTIAL FINANCIAL INC 05/13/2026 17.42 K $59.58 K   12.24% 0.02%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 16.42 K $56.15 K   -23.82% 0.02%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 16.33 K $55.85 K   -72.40% 0.02%
HSBC HOLDINGS PLC 04/30/2026 13.65 K $47.92 K   0.00% 0.02%
DIAMETRIC CAPITAL, LP 05/15/2026 11.98 K $40.97 K   100.00% 0.02%
NINE MASTS CAPITAL LTD 05/13/2026 11.70 K $40.01 K   100.00% 0.02%
GRAHAM CAPITAL MANAGEMENT, L.P. 05/15/2026 11.34 K $38.79 K   100.00% 0.01%
AMERICAN CENTURY COMPANIES INC 05/15/2026 10.29 K $35.21 K   100.00% 0.01%
BARCLAYS PLC 05/15/2026 8.60 K $29.41 K   -0.02% 0.01%
FMR LLC 05/15/2026 6.01 K $20.55 K   -2.32% 0.01%
VANGUARD GLOBAL ADVISERS, LLC 05/08/2026 4.64 K $15.86 K   100.00% 0.01%
GROUP ONE TRADING, L.P. 05/13/2026 3.91 K $13.36 K   681.40% 0.01%
SBI SECURITIES CO., LTD. 04/28/2026 2.64 K $9.03 K   -3.65% 0.00%
ROYAL BANK OF CANADA 05/15/2026 2.33 K $8.00 K   33.81% 0.00%
NISA INVESTMENT ADVISORS, LLC 04/30/2026 1.63 K $5.59 K   0.00% 0.00%
PNC FINANCIAL SERVICES GROUP, INC. 05/08/2026 1.17 K $4.01 K   0.00% 0.00%
CALDWELL SUTTER CAPITAL, INC. 05/06/2026 1.00 K $3.42 K   -50.00% 0.00%

Prelude Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 66 institutional investors and hedge funds held shares of Prelude Therapeutics Inc. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 10.91 M

BAKER BROS. ADVISORS LP: 10.12 M

Kynam Capital Management, LP: 1.59 M

EcoR1 Capital, LLC: 947,049

TWO SIGMA INVESTMENTS, LP: 923,626

SPHERA FUNDS MANAGEMENT LTD.: 558,339

39.99% of Prelude Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 34.05 M shares in the last 24 months. This purchase volume represents approximately $105.21 M in transactions.